Self-administered Drugs Market, By Type (Injectable Drugs, Transdermal Drugs, and Inhaled Drugs), By Indication, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Self-administered Drugs Market size was valued at US$ 88,514.6 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.
Self-administered drugs are medications that patients can take on their own, without the need for healthcare professionals. These medications can be delivered through both implanted and non-implantable infusion pumps that make contact with the skin\'s surface, as well as through over-the-counter, oral, and topical medicines. As more people lead active lifestyles, there is a growing demand for medications that save time and allow individuals to avoid hospital visits, except in emergencies. This shift is driving the expansion of the self-administered drugs market. Additionally, favorable reimbursement policies are expected to further boost market growth. The market is also set to grow due to factors like the migration of patient populations to developed countries and the rising cost of healthcare, which encourages patients to opt for self-administered drugs.
Self-administered Drugs Market- Market Dynamics
Ø Rise in chronic illnesses
The rise in chronic illnesses such as diabetes, hypertension, and autoimmune disorders is a major factor driving the growth of the self-administered drugs market. As the need for ongoing medication increases, self-administered drugs are becoming more popular, offering patients greater independence and convenience by allowing them to take their medications on their own schedule. These medications not only ease the burden on healthcare facilities but also enhance patients\' quality of life. Additionally, a cultural shift toward a more health-conscious society is encouraging individuals to become more proactive and informed about their healthcare, which is further increasing the demand for and acceptance of self-administered treatment options.
Self-administered Drugs Market- Segmentation Analysis:
The Global Self-administered Drugs Market is segmented on the basis of Type, Indication, and Region.
The market is segmented by type into Injectable Drugs, Transdermal Drugs, and Inhaled Drugs. In 2024, the Injectable Drugs category is expected to dominate the market. With the growing use of biologics and biosimilars, injectable self-administered drugs are gaining popularity. These medications often require precise dosing and administration, and recent advancements in auto-injectors and pre-filled syringes have made them easier to use at home. Injectable treatments for conditions such as rheumatoid arthritis, multiple sclerosis, and various hormonal imbalances are in high demand, as patients increasingly prefer the convenience of self-administration. According to the U.S. Food and Drug Administration (FDA), the number of biologics and biosimilars approved for market use has significantly increased in recent years, further fueling the growth of injectable medications. The market for injectables is expected to grow rapidly as more user-friendly and less painful delivery technologies continue to emerge.
Based on indication, the market is divided into Diabetes, Cardiovascular, Pain Management, Hormone Replacement, Osteoporosis, and Others. In 2024, the pain management category is projected to hold the largest market share. Pain management is a critical application area within the self-administered drugs market, reflecting the increasing demand for patient-friendly and effective treatments for both acute and chronic pain. Self-administered analgesics, including topical creams, oral medications, and transdermal patches, offer significant benefits in terms of convenience and flexibility, allowing patients to adjust their treatment as needed. The U.S. Centers for Disease Control and Prevention (CDC) reports that over 20% of Americans suffer from chronic pain, which is expected to continue driving the demand for self-managed pain relief options. The demand for self-managed pain management options is expected to rise due to the growing prevalence of conditions like neuropathic pain and arthritis, which will drive advancements in medication formulations and delivery systems.
Self-administered Drugs Market- Geographical Insights
In 2024, North America maintained a dominant position in the global self-administered drugs market. The growing prevalence of conditions such as diabetes, cancer, and bone diseases, along with a high demand for self-administered drugs among patients managing these conditions, are key drivers of market growth. Furthermore, governments in the region\'s major economies support the adoption of self-administered drugs by providing insurance coverage. The increasing number of USFDA drug approvals has also opened the door for new market players to expand. For example, in June 2020, the USFDA granted Eli Lilly and Company additional approvals for their novel rapid-acting insulin, \"Lyumjev,\" designed to help adults with type 1 and type 2 diabetes improve their glycemic control. Lyumjev, an innovative version of insulin lispro, was developed to lower A1C levels and enable faster insulin absorption, helping regulate blood sugar levels after meals. This new indication, available without a prescription, expands access to the drug for anyone, regardless of symptoms.
However, the Asia-Pacific region is expected to experience the fastest compound annual growth rate (CAGR) over the forecast period. Factors such as the rising prevalence of chronic illnesses, increasing healthcare costs, and improved access to healthcare services are driving the growing demand for convenient and affordable treatment options in the region. The aging population has brought greater focus to chronic disease management, contributing to the higher use of self-administered drugs. Additionally, investments in healthcare infrastructure and the expansion of the medical tourism industry are encouraging retail pharmacies to increase their online drug distribution.
Self-administered Drugs Market- Competitive Landscape:
Leading companies in the global self-administered drugs market include Omnicare, SFK Corporation, Johnson & Johnson, Cardinal Health, McKesson Corporation, and others. To stay competitive, these companies are employing various strategies, such as partnerships, collaborations, regional expansion, mergers and acquisitions, and new drug development. They are also significantly contributing to market growth by investing in research and development to enhance patient adherence and create innovative drug delivery systems. The continuous introduction of new products and technologies to meet the evolving needs of patients and healthcare professionals further intensifies competition in the market. For example, in September 2021, Abbott Laboratories announced the acquisition of Walk Vascular LLC, a medical device manufacturer. This acquisition expands Abbott\'s peripheral vascular portfolio and strengthens its endovascular therapeutic solutions, ultimately improving patient care.
Recent Developments:
February 2024: The FDA approved Novartis\' Xolair® (omalizumab), a self-injectable drug designed to prevent anaphylaxis and other allergic reactions in adults and children with IgE-mediated food allergies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SELF-ADMINISTERED DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Omnicare
Ø SFK Corporation
Ø Johnson & Johnson
Ø Cardinal Health
Ø McKesson Corporation
Ø Wal-Mart Stores Inc
Ø Express Scripts Holding Company
Ø CVS Health
Ø Walgreens Boots Alliance
Ø Rite Aid Corporation
Ø Others
GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Injectable Drugs
Ø Transdermal Drugs
Ø Inhaled Drugs
GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
Ø Diabetes
Ø Cardiovascular
Ø Pain Management
Ø Hormone Replacement
Ø Osteoporosis
Ø Others
GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o U.S.
o Canada
Ø Europe
o Germany
o UK
o France
o Italy
o Spain
o The Netherlands
o Sweden
o Russia
o Poland
o Rest of Europe
Ø Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
o Thailand
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Self-administered Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Self-administered Drugs Market Snippet by Type
2.1.2. Self-administered Drugs Market Snippet by Indication
2.1.3. Self-administered Drugs Market Snippet by Country
2.1.4. Self-administered Drugs Market Snippet by Region
2.2. Competitive Insights
3. Self-administered Drugs Key Market Trends
3.1. Self-administered Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Self-administered Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Self-administered Drugs Market Opportunities
3.4. Self-administered Drugs Market Future Trends
4. Self-administered Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Self-administered Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Self-administered Drugs Market Landscape
6.1. Self-administered Drugs Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Self-administered Drugs Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Injectable Drugs
7.1.3. Transdermal Drugs
7.1.4. Inhaled Drugs
8. Self-administered Drugs Market – By Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
8.1.2. Diabetes
8.1.3. Cardiovascular
8.1.4. Pain Management
8.1.5. Hormone Replacement
8.1.6. Osteoporosis
8.1.7. Others
9. Self-administered Drugs Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
9.2.1. Overview
9.2.2. Self-administered Drugs Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Self-administered Drugs Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.7. France
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.7.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.9. Spain
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.10. United Kingdom
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.11. Russia
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.12. Netherlands
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.13. Sweden
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.14. Poland
9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.3.15. Rest of Europe
9.3.15.1. Overview
9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Self-administered Drugs Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.8. South Korea
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.8.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.9. Japan
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Self-administered Drugs Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Self-administered Drugs Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Self-administered Drugs Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Omnicare
10.2.2. SFK Corporation
10.2.3. Johnson & Johnson
10.2.4. Cardinal Health
10.2.5. McKesson Corporation
10.2.6. Wal-Mart Stores Inc
10.2.7. Express Scripts Holding Company
10.2.8. CVS Health
10.2.9. Walgreens Boots Alliance
10.2.10. Rite Aid Corporation
10.2.11. Others
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
